BioAdvance News

Data on Cancer Resistance Pathway Inhibitor IT-139 to be Presented at AACR 2018 Annual Meeting

By WebmasterMarch 22, 2018November 1st, 2024No Comments

Data on Cancer Resistance Pathway Inhibitor IT-139 to be Presented at AACR 2018 Annual Meeting

Previous PostIView Therapeutics was awarded SBIR Innovative grant by NIH's National Institute of Allergy and Infectious Diseases (NIAID)
Next PostVenatoRx Pharmaceuticals to Present its Lead Clinical Antibacterial Candidate, VNRX-5133, at the American Chemical Society National Meeting